MarDee Haring-Layton - 28 Jan 2025 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Role
Chief Accounting Officer
Signature
/s/ MarDee Haring-Layton
Issuer symbol
DARE
Transactions as of
28 Jan 2025
Net transactions value
$0
Form type
4
Filing time
31 Jan 2025, 17:34:13 UTC
Previous filing
14 Mar 2024
Next filing
04 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DARE Employee Stock Option (right to buy) Award $0 +38,000 $0.000000 38,000 28 Jan 2025 Common stock 38,000 $3.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.